Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435052
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2023-02-01
Brief Title:
Efficacy of Eye Movement Desensitization Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
Sponsor:
Khushal Khan Khattak Univeristy Karak Pakistan
Organization:
Khushal Khan Khattak Univeristy Karak Pakistan
Study Overview
Official Title:
Efficacy of Eye Movement Desensitization Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan A Full-fledged Randomized Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This Randomized Controlled Trial will check the efficacy of Eye Movement Desensitization Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
Detailed Description:
This Randomized Controlled Trial will check the efficacy of Eye Movement Desensitization Reprocessing vs Cognitive Behavioral Therapy in Post-Traumatic Stress and Comorbid Disorders in Pakistan
It will be a single blind multi-center RCT with two arms EMDR and CBT This study will broadly work on following aims
1 Initially the comparative efficacy of EMDR and CBT ie standard face-to-face protcols will be determined on large scale in Pakistan by
1 Examining whether EMDR is non-inferior to CBT in the treatment of PTSD and its two comorbidities in Pakistan
2 Studying changes in the symptoms ie reduction in the PTSD and comorbid symptoms with the passage of time after administering EMDR and CBT The level of change in the symptoms will ultimately help in determining the extent of effectiveness of both therapies
3 Examine the reciprocal relationship between PTSD and comorbid symptoms for knowing whether any reduction in the PTSD symptoms can help in reducing the comorbid symptoms after administering EMDR and CBT
2 At the mean time work on the design and development of virtual EMDR and CBT therapies ie Web-based and Mobile Applications will also be started The initial prototypes will be tested for its comparative efficacy Later once the final versions will be developed then it will be also tested for its comparative efficacy on large scale in Pakistan
It will be a single blind multi-center RCT with two arms EMDR and CBT This study will broadly work on following aims
1 Initially the comparative efficacy of EMDR and CBT ie standard face-to-face protcols will be determined on large scale in Pakistan by
1 Examining whether EMDR is non-inferior to CBT in the treatment of PTSD and its two comorbidities in Pakistan
2 Studying changes in the symptoms ie reduction in the PTSD and comorbid symptoms with the passage of time after administering EMDR and CBT The level of change in the symptoms will ultimately help in determining the extent of effectiveness of both therapies
3 Examine the reciprocal relationship between PTSD and comorbid symptoms for knowing whether any reduction in the PTSD symptoms can help in reducing the comorbid symptoms after administering EMDR and CBT
2 At the mean time work on the design and development of virtual EMDR and CBT therapies ie Web-based and Mobile Applications will also be started The initial prototypes will be tested for its comparative efficacy Later once the final versions will be developed then it will be also tested for its comparative efficacy on large scale in Pakistan
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None